Literature DB >> 28490993

An mTOuR of Epilepsy in Tuberous Sclerosis Complex.

Ajay Gupta.   

Abstract

Entities:  

Year:  2017        PMID： 28490993      PMCID： PMC5416863          DOI： 10.5698/1535-7511.17.2.84

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  7 in total

Review 1.  The tuberous sclerosis complex.

Authors:  Peter B Crino; Katherine L Nathanson; Elizabeth Petri Henske
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

2.  "Epilepsy surgery recipes galore": in quest for the epileptogenic tuber in tuberous sclerosis complex.

Authors:  Ajay Gupta
Journal:  Epileptic Disord       Date:  2009-03       Impact factor: 1.819

3.  Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.

Authors:  Darcy A Krueger; Angus A Wilfong; Katherine Holland-Bouley; Anne E Anderson; Karen Agricola; Cindy Tudor; Maxwell Mays; Christina M Lopez; Mi-Ok Kim; David Neal Franz
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

4.  Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.

Authors:  Jacqueline A French; John A Lawson; Zuhal Yapici; Hiroko Ikeda; Tilman Polster; Rima Nabbout; Paolo Curatolo; Petrus J de Vries; Dennis J Dlugos; Noah Berkowitz; Maurizio Voi; Severine Peyrard; Diana Pelov; David N Franz
Journal:  Lancet       Date:  2016-09-06       Impact factor: 79.321

5.  Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.

Authors:  Lynsey Meikle; Kristen Pollizzi; Anna Egnor; Ioannis Kramvis; Heidi Lane; Mustafa Sahin; David J Kwiatkowski
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

6.  TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice.

Authors:  Elisabeth Abs; Susanna M I Goorden; Jadwiga Schreiber; Iris E Overwater; Marianne Hoogeveen-Westerveld; Caroline F Bruinsma; Elvedin Aganović; Nils Z Borgesius; Mark Nellist; Ype Elgersma
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

7.  Sirolimus for epilepsy in children with tuberous sclerosis complex: A randomized controlled trial.

Authors:  Iris E Overwater; André B Rietman; Karen Bindels-de Heus; Caspar W N Looman; Dimitris Rizopoulos; Tafadzwa M Sibindi; Perumpillichira J Cherian; Floor E Jansen; Henriëtte A Moll; Ype Elgersma; Marie-Claire Y de Wit
Journal:  Neurology       Date:  2016-08-10       Impact factor: 9.910
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.